Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Coronal serial sequential sampling of breast specimen in the assessment of the extent of ductal carcinoma in situ.

Mai KT, Stinson WA, Burns BF.

Arch Pathol Lab Med. 2009 Sep;133(9):1362; author reply 1362-3. doi: 10.1043/1543-2165-133.9.1362.b. No abstract available.

PMID:
19722734
2.

Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast.

Lester SC, Bose S, Chen YY, Connolly JL, de Baca ME, Fitzgibbons PL, Hayes DF, Kleer C, O'Malley FP, Page DL, Smith BL, Weaver DL, Winer E; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2009 Jan;133(1):15-25. doi: 10.1043/1543-2165-133.1.15. No abstract available.

PMID:
19123730
3.

Comparative analysis of size estimation by mapping and counting number of blocks with ductal carcinoma in situ in breast excision specimens.

Dadmanesh F, Fan X, Dastane A, Amin MB, Bose S.

Arch Pathol Lab Med. 2009 Jan;133(1):26-30. doi: 10.1043/1543-2165-133.1.26.

PMID:
19123732
4.

True colors.

Ginter P, Jones JG, Hoda SA.

Int J Surg Pathol. 2011 Aug;19(4):494-6. doi: 10.1177/1066896911411188. Epub 2011 Jun 10. No abstract available.

PMID:
21665859
5.

Examination of specimens from patients with ductal carcinoma in situ of the breast using large-format histology sections.

Tot T, Ibarra JA.

Arch Pathol Lab Med. 2009 Sep;133(9):1361; author reply 1361-2. doi: 10.1043/1543-2165-133.9.1361.b. No abstract available.

PMID:
19722732
6.
7.

Measurement of whole tumour size in breast cancer specimens.

Littleford S, Carder PJ.

Histopathology. 2005 Nov;47(5):543-4. No abstract available.

PMID:
16242009
8.

Measuring extent of ductal carcinoma in situ in breast excision specimens: a comparison of 4 methods.

Grin A, Horne G, Ennis M, O'Malley FP.

Arch Pathol Lab Med. 2009 Jan;133(1):31-7. doi: 10.1043/1543-2165-133.1.31.

PMID:
19123733
9.

[Management of ductal carcinoma in situ by the pathologist: current questions].

Arnould L, Caron Y, Sigal-Zafrani B.

Ann Pathol. 2003 Dec;23(6):534-46. Review. French.

PMID:
15094591
10.

Assessment of treatment for patients with primary ductal carcinoma in situ in the breast.

Gump FE.

Ann Surg Oncol. 1999 Jul-Aug;6(5):510-1. No abstract available.

PMID:
10458692
11.
12.

Nomogram for risk of relapse after breast-conserving surgery in ductal carcinoma in situ.

Mazouni C, Delaloge S, Rimareix F, Garbay JR.

J Clin Oncol. 2011 Jan 10;29(2):e44; author reply e45-6. doi: 10.1200/JCO.2010.32.3717. Epub 2010 Dec 6. No abstract available.

PMID:
21135281
13.

Part III. The pathobiology of ductal carcinoma in situ.

Catzavelos C.

Curr Probl Cancer. 2000 May-Jun;24(3):125-40. Review. No abstract available.

PMID:
10919315
14.

The effect of margins on the clinical management of ductal carcinoma in situ of the breast.

Meijnen P, Gilhuijs KG, Rutgers EJ.

J Surg Oncol. 2008 Dec 15;98(8):579-84. doi: 10.1002/jso.21041. Review.

PMID:
19072848
15.

Percentage of blocks with DCIS.

Goldstein N.

Breast Cancer Res Treat. 2001 Feb;65(3):259. No abstract available.

PMID:
11336248
17.
18.

Limits of resection for ductal carcinoma in situ.

Osteen RT.

J Surg Oncol. 1998 Oct;69(2):63-5. No abstract available.

PMID:
9808506
19.

Ductal carcinoma in-situ of the breast; second EORTC consensus meeting.

van Dongen JA, Holland R, Peterse JL, Fentiman IS, Lagios MD, Millis RR, Recht A.

Eur J Cancer. 1992;28(2-3):626-9. Review. No abstract available.

PMID:
1317200
20.

[In-situ ductal carcinoma of the breast; a retrospective clinico-pathological study].

Gelderman WA, Peterse JL, van Dongen JA, Cohen P.

Ned Tijdschr Geneeskd. 1986 Feb 15;130(7):308-10. Dutch. No abstract available.

PMID:
3005890

Supplemental Content

Support Center